Special Feature: New Therapies for Aplastic Anemia
Open Access
- 1 June 1986
- journal article
- special feature
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 291 (6) , 371-379
- https://doi.org/10.1097/00000441-198606000-00001
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Successful treatment of chronic refractory pure red cell aplasia with antithymocyte globulin: Correlation with in vitro erythroid culture studiesAmerican Journal of Hematology, 1984
- Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patientsBlood, 1984
- Aplastic AnemiaNew England Journal of Medicine, 1982
- Aplastic AnemiaNew England Journal of Medicine, 1982
- Mode of action of the IgG inhibitor of erythropoiesis in transient erythroblastopenia of childrenBlood, 1982
- Control of Antibody-Mediated Pure Red-Cell Aplasia by PlasmapheresisNew England Journal of Medicine, 1981
- Pure Red Cell AplasiaQJM: An International Journal of Medicine, 1978
- Paroxysmal Nocturnal Hemoglobinuria and Pure Red Cell AplasiaPostgraduate Medicine, 1974
- Studies on Red Cell Aplasia. V. PRESENCE OF ERYTHROBLAST CYTOTOXICITY IN γG-GLOBULIN FRACTION OF PLASMAJournal of Clinical Investigation, 1973
- Studies on red cell aplasia. I. Demonstration of a plasma inhibitor to heme synthesis and an antibody to erythroblast nuclei.Proceedings of the National Academy of Sciences, 1967